You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 19, 23 OCTOBER 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mycobacterium genavense Infection and Survival

Marshall J. Glesby, MD; Donald R. Hoover, PhD
Baltimore, Md

Arch Intern Med. 1995;155(19):2128.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the article by Pechère and colleagues1 on Mycobacterium genavense infection in patients with human immunodeficiency virus infection. Based on a comparison of survival with CD4 cell count—matched controls, the authors concluded that M genavense infection lessens survival. Clearly, there are biological reasons to believe that this disease could lessen survival. However, we suggest caution in attributing causality to M genavense infection and its treatment in the interpretation of the statistical relationships of these observational data.

An alternative explanation for the association of M genavense infection with decreased survival is that the mycobacterial infection is a marker of more severe immunosuppression that is not accounted for by CD4 cell count alone. Although controls were matched on CD4 cell count, this measure may be an incomplete marker of degree of immunosuppression in Pechère and colleagues' study as it is in other settings.2,3 Data from the Multicenter . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.